Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of activated integrin β7 in multiple myeloma patients.
Hosen N, Yoshihara S, Takamatsu H, Ri M, Nagata Y, Kosugi H, Shimomura Y, Hanamura I, Fuji S, Minauchi K, Kuroda J, Suzuki R, Nishimura N, Uoshima N, Nakamae H, Kawano Y, Mizuno I, Gomyo H, Suzuki K, Ozaki S, Nakamura S, Imai Y, Kizaki M, Negoro E, Handa H, Iida S. Hosen N, et al. Among authors: nishimura n. Int J Hematol. 2021 Jul;114(1):3-7. doi: 10.1007/s12185-021-03162-2. Epub 2021 May 17. Int J Hematol. 2021. PMID: 33999338
Gastric involvement, a rare site for extramedullary myeloma.
Kusano Y, Nishimura N, Yokoyama M, Terui Y, Hatake K. Kusano Y, et al. Among authors: nishimura n. Ann Hematol. 2016 Mar;95(4):663-4. doi: 10.1007/s00277-016-2596-z. Epub 2016 Jan 12. Ann Hematol. 2016. PMID: 26754637 Free article. No abstract available.
Myelomatous meningitis: a case report.
Kusano Y, Terui Y, Nishimura N, Yokoyama M, Ueda K, Hatake K. Kusano Y, et al. Among authors: nishimura n. Int J Hematol. 2016 Aug;104(2):149-50. doi: 10.1007/s12185-016-2024-0. Epub 2016 May 27. Int J Hematol. 2016. PMID: 27233510 No abstract available.
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.
Suzuki K, Tsukada N, Nishimura N, Nagata Y, Okazuka K, Mishima Y, Yokoyama M, Nishiwaki K, Ishida T, Yano S, Terui Y, Suzuki K. Suzuki K, et al. Among authors: nishimura n. Int J Hematol. 2020 Jan;111(1):103-111. doi: 10.1007/s12185-019-02764-1. Epub 2019 Oct 30. Int J Hematol. 2020. PMID: 31673952
The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y, Mishima Y, Shirouchi Y, Nishimura N, Yokoyama M, Okabe T, Inoue N, Uryu H, Fukuta T, Hatake K, Terui Y. Mishima Y, et al. Among authors: nishimura n. Int J Hematol. 2021 Feb;113(2):279-284. doi: 10.1007/s12185-020-02979-7. Epub 2020 Aug 30. Int J Hematol. 2021. PMID: 32864713
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.
Ozaki S, Handa H, Koiso H, Saitoh T, Sunami K, Ishida T, Suzuki K, Narita T, Iida S, Nakamura Y, Suzuki K, Nishimura N, Murakami H, Shimizu K. Ozaki S, et al. Among authors: nishimura n. J Cancer Res Clin Oncol. 2022 Jan;148(1):191-203. doi: 10.1007/s00432-021-03668-6. Epub 2021 Jun 2. J Cancer Res Clin Oncol. 2022. PMID: 34080068
1,357 results